Tolerability and Efficacy of Neoadjuvant Chemotherapy with a Tri-Weekly Interval Methotrexate, Doxorubicin, Vinblastine, and Cisplatin Regimen for Patients with Locally Advanced Bladder Cancer

OBJECTIVE: Compared with standard treatment, a modified tri-weekly MVAC (methotrexate, doxorubicin, vinblastine, and cisplatin) treatment regimen with a high cisplatin dose intensity shows good efficacy and lower toxicity. Thus, we retrospectively investigated the tolerability and efficacy of a modi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Rep Oncol
Autors principals: Arai, Satoko, Hara, Tomohiko, Matsui, Yoshiyuki, Koido, Keiichi, Hashimoto, Hironobu, Shinoda, Yasuo, Komiyama, Motokiyo, Fujimoto, Hiroyuki, Terakado, Hiroyuki
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2018
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6071437/
https://ncbi.nlm.nih.gov/pubmed/30079018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000490458
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars